Undetectable prostate specific antigen in disseminated prostate cancer

P Beardo*, PL Fernandez, JM Corral, Guiu G. Filella, J Alcover

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


Since 1984 prostate specific antigen (PSA) has been used for screening, diagnosis and followup of prostate cancer. Although this tissue marker is specific for organ and not for disease, many studies have confirmed its high ranking as a marker for prostate cancer, especially for followup after radical prostatectomy. At the time of PSA recurrence, tumor recurrence can be local and/or distant. We report our first case of distant tumor recurrence after radical prostatectomy without PSA recurrence.

Original languageEnglish
Pages (from-to)993-993
Number of pages1
JournalJ. Urol.
Issue number3
Publication statusPublished - Sept 2001


  • prostate-specific antigen
  • prostate
  • prostatic neoplasms


Dive into the research topics of 'Undetectable prostate specific antigen in disseminated prostate cancer'. Together they form a unique fingerprint.

Cite this